Enjoy complimentary customisation on priority with our Enterprise License!
The glycobiology market size is forecast to increase by USD 2.22 billion at a CAGR of 18.52% between 2023 and 2028.
The glycobiology industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
Glycobiology, a subdiscipline of biology, focuses on the study of glycans, complex carbohydrates, and their associated proteins and enzymes. These carbohydrates play essential roles in various biological processes, acting as structural components, energy sources, and mediators of cellular interactions. Glycans can be found as simple monosaccharides or complex structures attached to proteins or lipids. They are involved in protein folding, stability, solubility, and transport. Additionally, glycans are present on the surface of all cell types, serving as targets for specific recognition by other biomolecules, including glycan-binding proteins, glycan antigens, anti-glycan antibodies, lectin inhibitors, polysaccharides, glycosidase inhibitors, and glycosides. The importance of glycobiology extends to the development of drugs for chronic diseases, nanomedicine, glycan nanostructures, molecular diagnosis, antiviral therapeutics, vaccine development, drug delivery systems, and biomolecular therapeutics.
Technologies such as High-Performance Liquid Chromatography (HPLC), Mass Spectrometry (MS), Capillary Electrophoresis (CE), and proteomics examinations have significantly advanced glycomics research efforts. The global glycomics market is experiencing growth due to increasing healthcare spending, the diagnostic industry's expansion, and the potential of glycobiology in drug development for diseases like diabetes and obesity.
Get a glance at the Glycobiology Industry report of share of various segments Request Free Sample
The Drug discovery and development segment was valued at USD 495.40 billion in 2018 and showed a gradual increase during the forecast period.
Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market share of various regions, Request Free Sample
The market in North America is significantly large, driven by the presence of prominent pharmaceutical and biopharmaceutical companies and advanced healthcare infrastructure. The application of glycans in cancer research, particularly in breast, esophageal, pancreatic, gynecological, and rare cancers, is a major growth factor. In the US, approximately 237,000 breast cancer cases are diagnosed annually. The increasing incidence of chronic diseases, such as diabetes and obesity, and rising healthcare spending are further fueling market growth. Technologies like High-Performance Liquid Chromatography (HPLC), Mass Spectrometry (MS), and Capillary Electrophoresis (CE) are crucial for glycomics research. Pharmaceutical, biotechnology, and CROs are investing significantly in glycobiology for drug development, vaccine creation, and diagnostics.
Glycan nanostructures, glycosides, glycosaminoglycans (like Hyaluronan), and glycosidase inhibitors are key areas of focus. Market growth is expected to continue due to increasing analysis spending, administration group interest, and biomolecular therapeutics development.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Growing prevalence of cancer is the key driver of the market.
Advancements in field of glycobiology is the upcoming market trend.
What challenges does the Glycobiology Industry face during its growth?
Complex structure of glycansis is a key challenge affecting the industry growth.
Exclusive Customer Landscape
The glycobiology market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the glycobiology market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, glycobiology market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence In the industry.
Agilent Technologies Inc. - The market encompasses a range of products, including N-glycan workflow solutions featuring specialized glycobiology enzymes. These enzymes facilitate the analysis and modification of complex carbohydrate structures, playing a crucial role in various biochemical processes. By providing these advanced glycobiology tools, the company empowers researchers to delve deeper into the intricacies of glycosylation and uncover new insights into disease mechanisms and potential therapeutic targets.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Glycobiology, a subdiscipline of biology that focuses on the study of carbohydrates, or glycans, and their functions in living organisms, has emerged as a significant area of research and development in various sectors. The importance of glycobiology lies In the role of glycans in numerous biological processes, including cell recognition, signaling, and protein function. Glycan-binding proteins, such as lectins, play a crucial role in recognizing and interacting with specific glycan structures. These interactions are essential in various physiological processes, including immunology and development. Moreover, glycan antigens and anti-glycan antibodies have gained attention In the field of diagnostics, particularly in molecular diagnosis and vaccine development.
The development of glycosidase inhibitors and glycosides has opened new avenues for therapeutic applications. For instance, glycosidase inhibitors have shown potential In the treatment of chronic diseases, such as diabetes and obesity. Furthermore, glycomes and proteomes have emerged as essential tools In the understanding of complex biological systems. The application of glycobiology in nanomedicine and drug delivery systems has gained significant traction. Glycan nanostructures have shown promise in enhancing the specificity and efficacy of drug delivery systems, making them an attractive option for biotechnology and pharmaceutical firms. The glycomics research efforts and proteomics examination learnings have led to the identification of novel glycan structures and their functions.
These discoveries have paved the way for the development of new therapeutics, including antiviral therapeutics and biomolecular therapeutics. The global glycomics market is expected to witness significant growth due to the rising analysis spending by administration groups and the increasing focus on research and development In the sector. The proteomics sales have also been on the rise, driven by the growing demand for advanced diagnostic tools and therapeutic applications. The application of glycobiology in various sectors, including oncology, clinical trials, and diagnostics, has led to numerous breakthroughs. For instance, glycans have been identified as potential biomarkers for cancer diagnosis and prognosis.
Moreover, glycosylation patterns have been shown to play a crucial role In the development and progression of various cancers. The application of glycobiology in drug development has also gained significant attention, with several companies expanding their research and development efforts in this area. For example, Merck has been investing In the development of glycosylated therapeutic proteins for the treatment of various diseases. In conclusion, glycobiology is an essential area of research and development, with significant implications for various sectors, including diagnostics, drug development, and nanomedicine. The application of glycobiology In these areas has led to numerous breakthroughs and is expected to continue driving innovation and growth In the sector.
The potential of glycobiology In the development of novel therapeutics and diagnostic tools is vast, making it an exciting area of research for scientists and investors alike.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
174 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 18.52% |
|
Market growth 2024-2028 |
USD 2219.9 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
15.18 |
|
Key countries |
US, Germany, UK, Canada, and China |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
We can help! Our analysts can customize this glycobiology market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
